Page last updated: 2024-08-25

bw 12c79 and Liver Neoplasms

bw 12c79 has been researched along with Liver Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Braybrooke, JP; Dixon, RM; Ganesan, TS; Harris, AL; Levitt, NC; Littlewood, TJ; O'Byrne, K; Propper, DJ; Rajagopalan, B; Talbot, DC; Thompson, CH	1

Trials

1 trial(s) available for bw 12c79 and Liver Neoplasms

Article	Year
Phase II study of the oxygen saturation curve left shifting agent BW12C in combination with the hypoxia activated drug mitomycin C in advanced colorectal cancer. British journal of cancer, 2000, Volume: 82, Issue:11 Topics: Adult; Aged; Benzaldehydes; Cell Hypoxia; Colorectal Neoplasms; Drug Synergism; Drug Therapy, Combination; Female; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Mitomycin; Oxygen	2000

Article

Year

Phase II study of the oxygen saturation curve left shifting agent BW12C in combination with the hypoxia activated drug mitomycin C in advanced colorectal cancer.

British journal of cancer, 2000, Volume: 82, Issue:11

Topics: Adult; Aged; Benzaldehydes; Cell Hypoxia; Colorectal Neoplasms; Drug Synergism; Drug Therapy, Combination; Female; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Mitomycin; Oxygen

2000